Summit Trail Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-82,820
Closed -$334K 728
2018
Q1
$334K Buy
82,820
+9,502
+13% +$38.3K 0.06% 257
2017
Q4
$342K Buy
+73,318
New +$342K 0.04% 291